Organigram Makes First Strategic U.S. Investment in Phylos Bioscience to Commercialize THCV and Scale Seed Based Production
(marketscreener.com)
Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available
Organigram will launch new products in Canada containing THCV, a novel and rare cannabinoid referred to …
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has reached agreement with Phylos Bioscience Inc. …